Grant: Collaborative Research and Development Grants
McMaster University
$80,000.00
Development of a synthetic cannabinoid program
EF 2019-20
Résumé
This research proposal is concerned with the development of a totally synthetic chemical platform to access cannabidiol (CBD). CBD is a minor constituent in cannabis (Cannabis sativa) resin and is non-psychoactive and non-addictive. CBD has a growing list of therapeutic applications, for example in pain management such as migraine and neuropathic pain, as well as treatment of epilepsy and seizures. While natural cannabis resin is expected to be descheduled on October 17th 2018, access to synthetic CBD alleviates many of the problems (cost, inconsistent levels, fungal and insect infestations etc) faced in the growing cannabis industry. Reliable synthetic access to CBD will allow for reliable production and preparation of analogs that will permit a thorough investigation into the pain-management indications of this non-opiate based analgesic.
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
530888-2018
Name nom
Mcnulty, James
Department département
Chemistry & Chemical Biology
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2018
Award amount
80000
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Installment
inst:2 - 2
Partie
2
Nb partie
2
Application title
Development of a synthetic cannabinoid program
Keyword
NSERC
Application summary
This research proposal is concerned with the development of a totally synthetic chemical platform to access cannabidiol (CBD). CBD is a minor constituent in cannabis (Cannabis sativa) resin and is non-psychoactive and non-addictive. CBD has a growing list of therapeutic applications, for example in pain management such as migraine and neuropathic pain, as well as treatment of epilepsy and seizures. While natural cannabis resin is expected to be descheduled on October 17th 2018, access to synthetic CBD alleviates many of the problems (cost, inconsistent levels, fungal and insect infestations etc) faced in the growing cannabis industry. Reliable synthetic access to CBD will allow for reliable production and preparation of analogs that will permit a thorough investigation into the pain-management indications of this non-opiate based analgesic.